To examine the promoter methylation status of DOK6 in AML patients and further analyze their clinical significance, the MSP and BSP primer sets and assays were designed at the CpG islands of the DOK6 gene promoter (Figure 1A). The gene discussed is DOK6; the disease is acute myeloid leukemia.